PTC Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and welcome to the 39th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm. I want to thank everyone for logging in and joining us this week.
Our first presenting company this morning is PTC Therapeutics. It is my pleasure to welcome and introduce Stuart Peltz to tell us a little bit about the company.
A quick formatting note. There is a Q&A session after Stu's presentation. (Operator Instructions)
With that, Stu, let me pass it over to you for the presentation.
Yes. Thanks, Eric. Thanks, everyone. Welcome. Thanks for coming today. As shown on Slide 2 in our presentation, we'll be making some forward-looking statements, so I want to refer you to our SEC filings.
So as on Slide 3, I'm going to tell you today about how we're translating science to transform lives. And if you go to Slide 4, I think
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |